Clinical guideline variability in the diagnosis and care of people at risk for hereditary hematopoietic malignancy syndromes
Hamidi, A.; Roloff, G. W.; Shaw, R.; Acevedo, M.; Smith, S.; Drazer, M. W.
Show abstract
A growing understanding of the complexities of hematopoietic malignancies necessitates the existence of clinical recommendations that are sufficiently comprehensive. Although hereditary hematopoietic malignancies (HHMs) are increasingly recognized for conferring risk of myeloid malignancy, frequently utilized clinical recommendations have never been appraised for the ability to reliably guide HHM evaluation. We assessed established society-level clinical guidelines for inclusion of critical HHM genes and graded the strength of testing recommendations. We uncovered a substantial lack of consistency of recommendations guiding HHM evaluation. Such heterogeneity in guidelines likely contributes to refusal by payers to support HHM testing, leading to underdiagnoses and lost opportunities for clinical surveillance.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia 94%
- Monosomy 7/del(7q) Cause Sensitivity to Inhibitors of Nicotinamide Phosphoribosyltransferase in Acute Myeloid Leukemia 93%
- Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma 91%
Similar papers in this journal
- Exploring the role of Large Language Models (LLMs) in hematology: a systematic review of applications, benefits, and limitations 92%
- Validation of the IMPEDE VTE Score for Prediction of Venous Thromboembolism in Multiple Myeloma: A Retrospective Cohort Study 91%
- Platelet dysfunction in immune thrombocytopenia: finding clinical subsets with platelet phenotypes 89%
Similar papers in this journal
- Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid Leukemia 95%
- Mutational and transcriptional landscape of pediatric B-cell precursor lymphoblastic lymphoma 91%
- Multinational Assessment of Absolute Neutrophil Counts and White Blood Cell Counts Among Healthy Duffy Null Adults 90%
Similar papers in this journal
- Real World Predictors of Response and 24-month survival in high-grade TP53 -mutated Myeloid Neoplasms 93%
- High WEE1 expression is independently linked to poor survival in multiple myeloma 92%
- CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma 90%
Similar papers in this journal
- Clinical Impact of Panel Based Error Corrected Next Generation Sequencing versus Flow Cytometry to Detect Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML) 93%
- Convalescent plasma improves overall survival in patients with B-cell lymphoid malignancies and COVID-19: a longitudinal cohort and propensity score analysis 93%
- Single-cell transcriptomics predicts relapse in MLL-rearranged acute lymphoblastic leukemia in infants 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.